1 |
Geiser AG, Letterio JJ, Kulkarni AB, Karlsson S, Roberts AB, Sporn MB: Transforming growth factor beta 1 (TGF-beta 1) controls expression of major histocompatibility genes in the postnatal mouse: aberrant histocompatibility antigen expression in the pathogenesis of the TGF-beta 1 null mouse phenotype. Proc Natl Acad Sci U S A 90;9944-9948, 1993
DOI
ScienceOn
|
2 |
Nam JS, Terabe M, Kang MJ, Chae H, Voong N, Yang YA, Laurence A, Michalowska A, Mamura M, Lonning S, Berzofsky JA, Wakefield LM: Transforming growth factor beta subverts the immune system into directly promoting tumor growth through interleukin-17. Cancer Res 68;3915-3923, 2008
DOI
ScienceOn
|
3 |
Martin-Orozco N, Dong C: The IL-17/IL-23 axis of inflammation in cancer: friend or foe? Curr Opin Investig Drugs 10;543-549, 2009
PUBMED
|
4 |
Bierie B, Moses HL: Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer. Nat Rev Cancer 6;506-520, 2006
DOI
ScienceOn
|
5 |
McGeachy MJ, Chen Y, Tato CM, Laurence A, Joyce-Shaikh B, Blumenschein WM, McClanahan TK, O'Shea JJ, Cua DJ: The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo. Nat Immunol 10;314-324, 2009
DOI
ScienceOn
|
6 |
Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B: TGF beta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24;179-189, 2006
DOI
ScienceOn
|
7 |
Yang YA, Dukhanina O, Tang B, Mamura M, Letterio JJ, MacGregor J, Patel SC, Khozin S, Liu ZY, Green J, Anver MR, Merlino G, Wakefield LM: Lifetime exposure to a soluble TGF-beta antagonist protects mice against metastasis without adverse side effects. J Clin Invest 109;1607-1615, 2002
DOI
PUBMED
|
8 |
Kapp JA, Bucy RP: CD8+ suppressor T cells resurrected. Hum Immunol 69;715-720, 2008
DOI
ScienceOn
|
9 |
Nakae S, Komiyama Y, Nambu A, Sudo K, Iwase M,Homma I, Sekikawa K, Asano M, Iwakura Y: Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 17;375-387, 2002
|
10 |
Yamaguchi T, Sakaguchi S: Regulatory T cells in immune surveillance and treatment of cancer. Semin Cancer Biol 16;115-123, 2006
DOI
ScienceOn
|
11 |
Miyazono K, Kusanagi K, Inoue H: Divergence and convergence of TGF-beta/BMP signaling. J Cell Physiol 187;265-276, 2001
DOI
ScienceOn
|
12 |
Humphrey LJ, Singla O, Volenec FJ: Immunologic responsiveness of the breast cancer patient. Cancer 46;893-898, 1980
DOI
PUBMED
ScienceOn
|
13 |
Lee JC, Lee KM, Kim DW, Heo DS: Elevated TGF-beta1 secretion and down-modulation of NKG2D underlies impaired NK cytotoxicity in cancer patients. J Immunol 172;7335-7340, 2004
DOI
PUBMED
|
14 |
Roberts AB, Wakefield LM: The two faces of transforming growth factor beta in carcinogenesis. Proc Natl Acad Sci U S A 100;8621-8623, 2003
DOI
ScienceOn
|
15 |
Wrzesinski SH, Wan YY, Flavell RA: Transforming growth factor-beta and the immune response: implications for anticancer therapy. Clin Cancer Res 13;5262-5270, 2007
DOI
ScienceOn
|
16 |
Thomas DA, Massagu J: TGF-beta directly targets cytotoxic T cell functions during tumor evasion of immune surveillance. Cancer Cell 8;369-380, 2005
DOI
ScienceOn
|
17 |
Numasaki M, Fukushi J, Ono M, Narula SK, Zavodny PJ, Kudo T, Robbins PD, Tahara H, Lotze MT: Interleukin-17 promotes angiogenesis and tumor growth. Blood 101;2620-2627, 2003
DOI
ScienceOn
|
18 |
Wang L, Yi T, Kortylewski M, Pardoll DM, Zeng D, Yu H: IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway. J Exp Med 206;1457-1464, 2009
DOI
ScienceOn
|
19 |
Alleva DG, Burger CJ, Elgert KD: Tumor-induced regulation of suppressor macrophage nitric oxide and TNF-alpha production. Role of tumor-derived IL-10, TGF-beta, and prostaglandin E2. J Immunol 153;1674-1686, 1994
PUBMED
|
20 |
Yang L, Moses HL: Transforming growth factor beta: tumor suppressor or promoter? Are host immune cells the answer? Cancer Res 68;9107-9111, 2008
DOI
ScienceOn
|
21 |
Li MO, Wan YY, Sanjabi S, Robertson AK, Flavell RA: Transforming growth factor-beta regulation of immune responses. Annu Rev Immunol 24;99-146, 2006
DOI
ScienceOn
|
22 |
Chen F, Fujinaga T, Sato K, Sonobe M, Shoji T, Sakai H, Miyahara R, Bando T, Okubo K, Hirata T, Toi M, Date H: Clinical features of surgical resection for pulmonary metastasis from breast cancer. Eur J Surg Oncol 35;393-397, 2009
DOI
PUBMED
ScienceOn
|
23 |
Mantovani A, Allavena P, Sica A, Balkwill F: Cancer-related inflammation. Nature 454;436-444, 2008
DOI
ScienceOn
|
24 |
Zwirner NW, Fuertes MB, Girart MV, Domaica CI, Rossi LE: Cytokine-driven regulation of NK cell functions in tumor immunity: role of the MICA-NKG2D system. Cytokine Growth Factor Rev 18;159-170, 2007
DOI
ScienceOn
|
25 |
Miyahara Y, Odunsi K, Chen W, Peng G, Matsuzaki J, Wang RF: Generation and regulation of human CD4+ IL-17- producing T cells in ovarian cancer. Proc Natl Acad Sci U S A 105;15505-15510, 2008
DOI
ScienceOn
|
26 |
Kryczek I, Wei S, Szeliga W, Vatan L, Zou W: Endogenous IL-17 contributes to reduced tumor growth and metastasis.Blood 114;357-359, 2009
DOI
ScienceOn
|
27 |
Ljunggren HG, K rre K: In search of the ‘missing self: MHC molecules and NK cell recognition. Immunol Today 11; 237-244, 1990
DOI
ScienceOn
|
28 |
Nam JS, Terabe M, Mamura M, Kang MJ, Chae H, Stuelten C, Kohn E, Tang B, Sabzevari H, Anver MR, Lawrence S, Danielpour D, Lonning S, Berzofsky JA, Wakefield LM: An anti-transforming growth factor beta antibody suppresses metastasis via cooperative effects on multiple cell compartments. Cancer Res 68;3835-3843, 2008
DOI
ScienceOn
|
29 |
Kortylewski M, Xin H, Kujawski M, Lee H, Liu Y, Harris T, Drake C, Pardoll D, Yu H: Regulation of the IL-23 and IL-12 balance by Stat3 signaling in the tumor microenvironment. Cancer Cell 15;114-123, 2009
DOI
ScienceOn
|
30 |
Kitamura T, Kometani K, Hashida H, Matsunaga A, Miyoshi H, Hosogi H, Aoki M, Oshima M, Hattori M, Takabayashi A, Minato N, Taketo MM: SMAD4-deficient intestinal tumors recruit CCR1+ myeloid cells that promote invasion. Nat Genet 39;467-475, 2007
DOI
ScienceOn
|
31 |
Ge R, Rajeev V, Ray P, Lattime E, Rittling S, Medicherla S, Protter A, Murphy A, Chakravarty J, Dugar S, Schreiner G, Barnard N, Reiss M: Inhibition of growth and metastasis of mouse mammary carcinoma by selective inhibitor of transforming growth factor-beta type I receptor kinase in vivo. Clin Cancer Res 12;4315-4330, 2006
DOI
ScienceOn
|
32 |
Denoix PF: Enquete permanent dans les centres anticancereaux. Bull Inst Nat Hyg 1;70-75, 1946
|
33 |
Ghiringhelli F, Puig PE, Roux S, Parcellier A, Schmitt E, Solary E, Kroemer G, Martin F, Chauffert B, Zitvogel L: Tumor cells convert immature myeloid dendritic cells into TGF-beta-secreting cells inducing CD4+CD25+ regulatory T cell proliferation. J Exp Med 202;919-929, 2005
DOI
ScienceOn
|